Correlation of Vitamin D deficiency with Type 2 diabetes and metabolic traits in the Indian population


  • Ashish H. Bajaj Department of Pharmacology, D. Y. Patil University, School of Medicine, Nerul, Navi Mumbai, Maharashtra, India
  • Suchanda Gadre Department of Pharmacology, D. Y. Patil University, School of Medicine, Nerul, Navi Mumbai, Maharashtra, India
  • Sangita Sukumaran Department of Pharmacology, Terna Medical College, Nerul, Navi Mumbai, Maharashtra, India
  • Deepali Vidhate Department of Biochemistry, D. Y. Patil University, School of Medicine, Nerul, Navi Mumbai, Maharashtra, India



Vitamin D, Type 2 diabetes mellitus, Lipid profile, Serum cholesterol


Background: In India, 30-50% of children and 50-80% of adults are Vitamin D deficient. Limited data exists to assess the association of Vitamin D status, Type 2 diabetes (T2D), and metabolic traits in Indians. This study was conducted to assess the correlation of Vitamin D deficiency with T2D and metabolic risk factors in the Indian population.

Methods: Patients of either gender visiting medicine outpatient department over a period of 1-year and with Vitamin D deficiency (levels <20 ng/ml), not taking Vitamin D supplements and having T2D were selected for the study. Participants were tested for serum Vitamin D, fasting blood sugar, and lipid profile parameters. Correlation between Vitamin D deficiency and blood sugar and Vitamin D deficiency and lipid profile was assessed using Pearson’s correlation test.

Results: Out of 144 subjects, number of diabetic patients were 74 (51.38%) and non-diabetic patients were 70 (48.61%). Among diabetic patients, 10/74 (13.51%) were Vitamin D deficient and among non-diabetic patients, 20/70 (28.57%) were Vitamin D deficient. There was an inverse correlation between Vitamin D and total cholesterol (p=0.01) and Vitamin D and low-density lipoprotein (p=0.01), and it was statistically significant (p<0.05).

Conclusion: Assessment of Vitamin D levels can be useful in diabetic patients as its deficiency is associated with T2D.


Holick MF, Chen TC. Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr. 2008;87(4):1080S-6.

Ramagopalan SV, Heger A, Berlanga AJ, Maugeri NJ, Lincoln MR, Burrell A, et al. A ChIP-seq defined genome-wide map of vitamin D receptor binding: associations with disease and evolution. Genome Res. 2010;20(10):1352-60.

Heaney RP. Long-latency deficiency disease: insights from calcium and vitamin D. Am J Clin Nutr. 2003;78(5):912-9.

Davis CD. Vitamin D and cancer: current dilemmas and future research needs. Am J Clin Nutr. 2008;88(2):565S-9.

Aranow C. Vitamin D and the immune system. J Investig Med. 2011;59(6):881-6.

Mitri J, Muraru MD, Pittas AG. Vitamin D and type 2 diabetes: a systematic review. Eur J Clin Nutr. 2011;65(9):1005-15.

Vacek JL, Vanga SR, Good M, Lai SM, Lakkireddy D, Howard PA. Vitamin D deficiency and supplementation and relation to cardiovascular health. Am J Cardiol. 2012;109(3):359-63.

Renzaho AM, Halliday JA, Nowson C. Vitamin D, obesity, and obesity-related chronic disease among ethnic minorities: a systematic review. Nutrition. 2011;27(9):868-79.

Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357(3):266-81.

Harinarayan CV, Ramalakshmi T, Venkataprasad U. High prevalence of low dietary calcium and low Vitamin D status in healthy south Indians. Asia Pac J Clin Nutr. 2004;13(4):359-64.

Braun TR, Been LF, Blackett PR, Sanghera DK. Vitamin D deficiency and cardio-metabolic risk in a north Indian community with highly prevalent type 2 diabetes. J Diabetes Metab. 2012;3.

Simonen PP, Gylling HK, Miettinen TA. Diabetes contributes to cholesterol metabolism regardless of obesity. Diabetes Care. 2011;25(9):1511-5.

International Diabetes Federation. IDF Diabetes Atlas. 5th Edition. Brussels, Belgium: International Diabetes Federation; 2011.

Liel Y, Ulmer E, Shary J, Hollis BW, Bell NH. Low circulating vitamin D in obesity. Calcif Tissue Int. 1988;43(4):199-201.

Hamilton B. Vitamin D and human skeletal muscle. Scand J Med Sci Sports. 2010;20(2):182-90.

Parikh SJ, Edelman M, Uwaifo GI, Freedman RJ, Semega-Janneh M, Reynolds J, et al. The relationship between obesity and serum 1,25-dihydroxy vitamin D concentrations in healthy adults. J Clin Endocrinol Metab. 2004;89(3):1196-9.

Oh J, Weng S, Felton SK, Bhandare S, Riek A, Butler B, et al. 1,25(OH)2 vitamin d inhibits foam cell formation and suppresses macrophage cholesterol uptake in patients with type 2 diabetes mellitus. Circulation. 2009;120(8):687-98.

Hyppönen E, Power C. Vitamin D status and glucose homeostasis in the 1958 British birth cohort: the role of obesity. Diabetes Care. 2006;29(10):2244-6.

Palomer X, González-Clemente JM, Blanco-Vaca F, Mauricio D. Role of vitamin D in the pathogenesis of type 2 diabetes mellitus. Diabetes Obes Metab. 2008;10(3):185-97.




How to Cite

Bajaj, A. H., Gadre, S., Sukumaran, S., & Vidhate, D. (2017). Correlation of Vitamin D deficiency with Type 2 diabetes and metabolic traits in the Indian population. International Journal of Basic & Clinical Pharmacology, 4(6), 1224–1227.



Original Research Articles